The vitamin D system is deregulated in pancreatic diseases

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PART B, 2014, Pages

  Hummel, Doris ^a   Aggarwal, Abhishek ^a   Borka, Katalin ^b   Bajna, Erika ^a   Kállay, Enikö ^a   Horváth, Henrik Csaba ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

CaSR; Chronic pancreatitis; CYP24A1; Pancreatic cancer; Pancreatic ductal adenocarcinoma; VDR; Vitamin D

Indexed keywords

1,25 DIHYDROXYVITAMIN 24 HYDROXYLASE; CALCITRIOL; CALCIUM SENSING RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CASR PROTEIN, HUMAN; COLECALCIFEROL 24 HYDROXYLASE; CYP24A1 PROTEIN, HUMAN; VDR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS ISLET; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PANCREATITIS;

ADULT; AGED; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; VITAMIN D; VITAMIN D3 24-HYDROXYLASE;

EID: 84906856039     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.07.011     Document Type: Article

References (54)

1. M. Hidalgo Pancreatic cancer New Engl. J. Med. 362 2010 1605 1617
2. C.J. Rosen, J.S. Adams, D.D. Bikle, D.M. Black, M.B. Demay, J.E. Manson, M.H. Murad, and C.S. Kovacs The nonskeletal effects of vitamin D: an endocrine society scientific statement Endocr. Rev. 33 2012 456 492
3. A.W. Norman From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health Am. J. Clin. Nutr. 88 2008 491S-499S
4. K. Townsend, K.N. Evans, M.J. Campbell, K.W. Colston, J.S. Adams, and M. Hewison Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment J. Steroid Biochem. Mol. Biol. 97 2005 103 109 (Pubitemid 41546219)
5. J.W. Pike, and M.B. Meyer The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3 Rheum. Dis. Clin. North Am. 38 2012 13 27
6. I. Schuster Cytochromes P450 are essential players in the vitamin D signaling system Biochim. Biophys. Acta 1814 2011 186 199
7. J. Höbaus, U. Thiem, D.M. Hummel, and E. Kallay Role of Calcium, vitamin D, and the extrarenal vitamin D hydroxylases during carcinogenesis Anticancer Agents Med. Chem. 13 2013 20 35
8. L. Canaff, and G.N. Hendy Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D J. Biol. Chem. 277 2002 30337 30350
9. P.E. Squires, T.E. Harris, S.J. Persaud, S.B. Curtis, A.M. Buchan, and P.M. Jones The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion Diabetes 49 2000 409 417 (Pubitemid 30131786)
10. M. McCullough, R. Bostick, and T.L. Mayo Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer Ann. Rev. Nutr. 29 2009 111 132
11. L.N. Anderson, M. Cotterchio, J.A. Knight, A. Borgida, S. Gallinger, and S.P. Cleary Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in Ontario, Canada PLoS One 8 2013 e66768
12. S.B. Mohr, C.F. Garland, E.D. Gorham, W.B. Grant, and F.C. Garland Ultraviolet B irradiance and vitamin D status are inversely associated with incidence rates of pancreatic cancer worldwide Pancreas 39 2010 669 674
13. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS 2006 Vitamin D. intake and the risk for pancreatic cancer in two cohort studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15:1688-1695. (Pubitemid 44497105)
14. L.B. Zablotska, Z. Gong, F. Wang, E.A. Holly, and P.M. Bracci Vitamin D calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area Cancer Causes Control:CCC 22 2011 91 100
15. R.Z. Stolzenberg-Solomon, E.J. Jacobs, A.A. Arslan, D. Qi, A.V. Patel, K.J. Helzlsouer, S.J. Weinstein, M.L. McCullough, M.P. Purdue, X.O. Shu, K. Snyder, J. Virtamo, L.R. Wilkins, K. Yu, A. Zeleniuch-Jacquotte, W. Zheng, D. Albanes, Q. Cai, C. Harvey, R. Hayes, S. Clipp, R.L. Horst, L. Irish, K. Koenig, L. Le Marchand, and L.N. Kolonel Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers Am. J. Epidemiol. 172 2010 81 93
16. R.Z. Stolzenberg-Solomon, R. Vieth, A. Azad, P. Pietinen, P.R. Taylor, J. Virtamo, and D. Albanes A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers Cancer Res. 66 2006 10213 10219 (Pubitemid 44672077)
17. R.Z. Stolzenberg-Solomon, R.B. Hayes, R.L. Horst, K.E. Anderson, B.W. Hollis, and D.T. Silverman Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial Cancer Res. 69 2009 1439 1447
18. S.L. Liu, Y.P. Zhao, M.H. Dai, L. You, Z. Wen, and J.W. Xu Vitamin D status and the risk of pancreatic cancer: a meta-analysis Chin. Med. J. 126 2013 3356 3359
19. B.M. Wolpin, K. Ng, Y. Bao, P. Kraft, M.J. Stampfer, D.S. Michaud, J. Ma, J.E. Buring, H.D. Sesso, I.M. Lee, N. Rifai, B.B. Cochrane, J. Wactawski-Wende, R.T. Chlebowski, W.C. Willett, J.E. Manson, E.L. Giovannucci, and C.S. Fuchs Plasma 25-hydroxyvitamin D and risk of pancreatic cancer Cancer Epidemiol. Biomarkers Prev. 21 2012 82 91
20. Y. Bao, K. Ng, B.M. Wolpin, D.S. Michaud, E. Giovannucci, and C.S. Fuchs Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies Br. J. Cancer 102 2010 1422 1427
21. M. Cho, P.F. Peddi, K. Ding, L. Chen, D. Thomas, J. Wang, A.C. Lockhart, B. Tan, and A. Wang-Gillam Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma J. Transl. Med. 11 2013 206
22. WHO Pathology and Genetics of Tumours of the Digestive System 2000 IARC Press Lyon
23. D.M. Hummel, U. Thiem, J. Höbaus, I. Mesteri, L. Gober, C. Stremnitzer, J. Graça, B. Obermayer-Pietsch, and E. Kallay Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis J. Steroid Biochem. Mol. Biol. 136 2013 284 288
24. C. Rubie, K. Kempf, J. Hans, T. Su, B. Tilton, T. Georg, B. Brittner, B. Ludwig, and M. Schilling Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues Mol. Cell Probes 19 2005 101 109 (Pubitemid 40174728)
25. H.C. Horváth, P. Lakatos, J.P. Kósa, K. Bácsi, K. Borka, G. Bises, T. Nittke, P.A. Hershberger, G. Speer, and E. Kállay The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis J. Histochem. Cytochem. 58 2010 277 285
26. I.S. Fetahu, D.M. Hummel, T. Manhardt, A. Aggarwal, S. Baumgartner-Parzer, and E. Kállay Regulation of the calcium-sensing receptor expression by 1,25-dihydroxyvitamin D3, interleukin -6, and tumor necrosis factor alpha in colon cancer cells J. Steroid Biochem. Mol. Biol. 2014 (in press)
27. A. Heindl, A.K. Seewald, T. Thalhammer, G. Bises, M. Schepelmann, H. Uhrova, S. Dekan, I. Mesteri, R. Rogojanu, and I. Ellinger Automated recognition of tissue-associated erythrocytes (ARETE)-a new tool in tissue cytometry Cytometry A 83 2013 363 374
28. G. Zhang, A. Schetter, P. He, N. Funamizu, J. Gaedcke, B.M. Ghadimi, T. Ried, R. Hassan, H.G. Yfantis, D.H. Lee, C. Lacy, A. Maitra, N. Hanna, H.R. Alexander, and S.P. Hussain DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma PLoS One 7 2012 e31507
29. G.Z. Rácz, A. Kittel, D. Riccardi, R.M. Case, A.C. Elliott, and G. Varga Extracellular calcium sensing receptor in human pancreatic cells Gut 51 2002 705 711 (Pubitemid 35216860)
30. K.K. Deeb, D.L. Trump, and C.S. Johnson Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nat. Rev. Cancer 7 2007 684 700 (Pubitemid 47327412)
31. S. Christakos, P. Dhawan, Y. Liu, X. Peng, and A. Porta New insights into the mechanisms of vitamin D action J. Cell. Biochem. 88 2003 695 705 (Pubitemid 36258819)
32. G. Jones, S.A. Strugnell, and H.F. DeLuca Current understanding of the molecular actions of vitamin D Physiol. Rev. 78 1998 1193 1231 (Pubitemid 28491953)
33. J.W. Pike, and N.K. Shevde The vitamin D receptor D. Feldman, J.W. Pike, F.H. Gorieux, Vitamin D 2005 Elsevier Academic Press Amsterdam 167 191
34. K. Townsend, C.M. Banwell, M. Guy, K.W. Colston, J.L. Mansi, P.M. Stewart, M.J. Campbell, and M. Hewison Autocrine metabolism of vitamin D in normal and malignant breast tissue Clin. Cancer Res. 11 2005 3579 3586 (Pubitemid 40627915)
35. H.S. Cross, and E. Kállay Nutritional regulation of extrarenal vitamin D hydroxylase expression - potential application in tumor prevention and therapy Future Oncol. 1 2005 415 424
36. H.S. Cross, G. Bises, D. Lechner, T. Manhardt, and E. Kallay The Vitamin D endocrine system of the gut-its possible role in colorectal cancer prevention J. Steroid Biochem. Mol. Biol. 97 2005 121 128 (Pubitemid 41546221)
37. K. Mimori, Y. Tanaka, K. Yoshinaga, T. Masuda, K. Yamashita, M. Okamoto, H. Inoue, and M. Mori Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer Ann. Oncol. 15 2004 236 241 (Pubitemid 38262621)
38. D.S. Klimstra, and D.S. Longnecker K-ras mutations in pancreatic ductal proliferative lesions Am. J. Pathol. 145 1994 1547 1550 (Pubitemid 24378508)
39. E. Rozenblum, M. Schutte, M. Goggins, S.A. Hahn, S. Panzer, M. Zahurak, S.N. Goodman, T.A. Sohn, R.H. Hruban, C.J. Yeo, and S.E. Kern Tumor-suppressive pathways in pancreatic carcinoma Cancer Res. 57 1997 1731 1734 (Pubitemid 27199667)
40. Q. Zhang, B. Kanterewicz, S. Shoemaker, Q. Hu, S. Liu, K. Atwood, and P. Hershberger Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH) 2D3) in non-small cell lung cancer cells with distinct oncogene mutations J. Steroid Biochem. Mol. Biol. 136 2013 264 270
41. E. Albrechtsson, T. Jonsson, S. Möller, M. Höglund, B. Ohlsson, and J. Axelson Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number Pancreatology 3 2003 41 46 (Pubitemid 36351177)
42. Chiang, C.N. Yeh, S.C. Chen, S.C. Shen, J.T. Hsu, T.S. Yeh, J.H. Pang, L.J. Su, M. Takano, A. Kittaka, H.H. Juang, and T.C. Chen MART-10, a new generation of vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D(3) in inhibiting cell proliferation and inducing apoptosis in ER+ MCF-7 breast cancer cells Evid Based Complement. Alternat. Med. 2012 310872
43. G.G. Schwartz, D. Eads, C. Naczki, S. Northrup, T. Chen, and C. Koumenis 19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo Cancer Biol. Ther. 7 2008 430 436 (Pubitemid 351847063)
44. L. Li, B. Wu, L. Yang, G. Yin, W. Wei, S. Sui, and J. Liu Association of vitamin D receptor gene polymorphisms with pancreatic cancer: a pilot study in a North China population Oncol. Lett. 5 2013 1731 1735
45. U. Zeitz, K. Weber, D.W. Soegiarto, E. Wolf, R. Balling, and R.G. Erben Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor FASEB J. 17 2003 509 511
46. M. Chakhtoura, and S.T. Azar The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus Int. J. Endocrinol. 2013 148673
47. M.F. Holick Vitamin D deficiency New Engl. J. Med. 357 2007 266 281
48. B. Frederiksen, E. Liu, J. Romanos, A.K. Steck, X. Yin, M. Kroehl, T.E. Fingerlin, H. Erlich, G.S. Eisenbarth, M. Rewers, and J.M. Norris Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY) J. Steroid Biochem. Mol. Biol. 133 2013 51 57
49. H. Wolden-Kirk, D. Rondas, M. Bugliani, H. Korf, L. Van Lommel, K. Brusgaard, H.T. Christesen, F. Schuit, P. Proost, M. Masini, P. Marchetti, D.L. Eizirik, L. Overbergh, and C. Mathieu Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans Endocrinology 155 2014 736 747
50. C. Calle, J. Campión, M. García-Arencibia, B. Maestro, and N. Dávila Transcriptional inhibition of the human insulin receptor gene by aldosterone J. Steroid Biochem. Mol. Biol. 84 2003 543 553 (Pubitemid 36588808)
51. J.A. Alvarez, and A. Ashraf Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis Int. J. Endocrinol. 2010 351385
52. R.Z. Stolzenberg-Solomon, B.I. Graubard, S. Chari, P. Limburg, P.R. Taylor, J. Virtamo, and D. Albanes Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers JAMA 294 2005 2872 2878 (Pubitemid 41785868)
53. P.B. White, E.M. True, K.M. Ziegler, S.S. Wang, D.A. Swartz-Basile, H.A. Pitt, and N.J. Zyromski Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth J. Gastrointest. Surg. 14 2010 1888 1893 discussion 1893-1884
54. A.G. Faure-Dussert, A.P. Delbancut, and B.J. Billaudel Low extracellular calcium enhances beta cell sensitivity to the stimulatory influence of 1,25-dihydroxyvitamin D3 on insulin release by islets from vitamin D3-deficient rats Steroids 62 1997 554 562 (Pubitemid 27319206)